Skip to main content

Advertisement

SpringerLink
Log in

Subclinical hypothyroidism and the development of heart failure: an overview of risk and effects on cardiac function

  • Review
  • Published:
Clinical Research in Cardiology Aims and scope Submit manuscript

Abstract

The prevalence of subclinical hypothyroidism (SCH) ranges from 5 to 15% of the general population. However, it remains controversial if SCH warrants life-long thyroxine replacement therapy. Patients with a thyroid-stimulating hormone (TSH) level > 10 mIU/L have a higher risk of developing heart failure with reduced ejection fraction as compared to subjects with normal thyroid function. However, abnormally high TSH levels could also be connected with an overall lower metabolic rate and better survival in elderly subjects. The potential mechanisms responsible for diastolic dysfunction of the left ventricle (LV) in SCH are connected with endothelial dysfunction and arterial stiffness, inflammatory state and are driven by TSH apoptosis-derived microparticles. The impact of SCH on LV systolic function is more controversial, and it is connected not only with cardiac remodelling but also with predisposition of patients with SCH to the conditions leading to heart failure. This review presents an overview of processes in the context of potential benefits of thyroxine supplementation therapy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Surks MI, Ortiz E, Daniels GH et al (2004) Subclinical thyroid disease. JAMA 291:228–243

    Article  CAS  PubMed  Google Scholar 

  2. Ripoli A, Pingitore A, Favilli B et al (2005) Does subclinical hypothyroidism affect cardiac pump performance? Evidence from a magnetic resonance imaging study. J Am Coll Cardiol 45:439–445

    Article  PubMed  Google Scholar 

  3. Redford C, Vaidya B (2017) Subclinical hypothyroidism: should we treat? Post Reprod Health 23:55–62

    Article  PubMed  Google Scholar 

  4. Störk S, Handrock R, Jacob J et al (2017) Epidemiology of heart failure in Germany: a retrospective database study. Clin Res Cardiol 106(11):913–922

    Article  PubMed  PubMed Central  Google Scholar 

  5. Rodondi N, Newman AB, Vittinghoff E et al (2005) Subclinical hypothyroidism and the risk of heart failure, other cardiovascular events, and death. Arch Intern Med 165:2460–2466

    Article  PubMed  Google Scholar 

  6. Biondi B (2012) Mechanisms in endocrinology: Heart failure and thyroid dysfunction. Eur J Endocrinol 167(5):609–618

    Article  CAS  PubMed  Google Scholar 

  7. Rodondi N, den Elzen WP, Bauer DC et al (2010) Subclinical hypothyroidism the risk of coronary heart disease mortality. JAMA 304(12):1365–1374

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Gencer B, Collet TH, Virgini V et al (2012) Thyroid Studies C. Subclinical thyroid dysfunction and the risk of heart failure events: an individual participant data analysis from 6 prospective cohorts. Circulation 126:1040–1049

    Article  CAS  PubMed  Google Scholar 

  9. Chaker L, Bianco AC, Jonklaas J, Peeters RP (2017) Hypothyroidism. Lancet 390:1550–1562

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Parretti H, Okosieme O, Vanderpump M (2016) Current recommendations in the management of hypothyroidism: developed from a statement by the British Thyroid Association Executive. Br J Gen Pract 66:538–540

    Article  PubMed  PubMed Central  Google Scholar 

  11. Floriani C, Gencer B, Collet TH, Rodondi N (2018) Subclinical thyroid dysfunction and cardiovascular diseases: 2016 update. Eur Heart J 14(7):503–507 39(

    Article  CAS  Google Scholar 

  12. Chen S, Shauer A, Zwas DA, Lotan C, Keren A, Gotsman I (2014) The effect of thyroid function on clinical outcome in patients with heart failure. Eur J Heart Fail 16(2):217–226

    Article  CAS  PubMed  Google Scholar 

  13. Gencer B, Collet TH, Virgini V, Auer R, Rodondi N (2013) Subclinical thyroid dysfunction and cardiovascular outcomes among prospective cohort studies. Endocr Metab Immune Disord Drug Targets 13:4–12

    Article  CAS  PubMed  Google Scholar 

  14. Hayashi T, Hasegawa T, Kanzaki H et al (2016) Subclinical hypothyroidism is an independent predictor of adverse cardiovascular outcomes in patients with acute decompensated heart failure. ESC Heart Fail 3:168–176

    Article  PubMed  PubMed Central  Google Scholar 

  15. Gussekloo J, van Exel E, de Craen AJ, Meinders AE, Frölich M, Westendorp RG (2004) Thyroid status, disability and cognitive function, and survival in old age. JAMA 292:2591–2599

    Article  CAS  PubMed  Google Scholar 

  16. Ponikowski P, Voors AA, Anker SD et al (2016) 2016 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure. Rev Esp Cardiol (Engl Ed 69:1167

    Google Scholar 

  17. Lam CS, Lyass A, Kraigher-Krainer E et al (2011) Cardiac dysfunction and noncardiac dysfunction as precursors of heart failure with reduced and preserved ejection fraction in the community. Circulation 124:24–30

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Hammoudi N, Laveau F, Helft G et al (2017) Low level exercise echocardiography helps diagnose early stage heart failure with preserved ejection fraction: a study of echocardiography versus catheterization. Clin Res Cardiol 106(3):192–201

    Article  PubMed  Google Scholar 

  19. Morbach C, Buck T, Rost C et al (2018 Feb) Point-of-care B-type natriuretic peptide and portable echocardiography for assessment of patients with suspected heart failure in primary care: rationale and design of the three-part Handheld-BNP program and results of the training study. Clin Res Cardiol 107(2):95–107

    Article  CAS  PubMed  Google Scholar 

  20. Vitale G, Maurizio G, Gelsy AL et al (2002) Left ventricular myocardial impairment in subclinical hypothyroidism assessed by a new ultrasound tool: pulsed tissue Doppler. J Clin Endocrinol Metab 87:4350–4355

    Article  CAS  PubMed  Google Scholar 

  21. Zoncu S, Pigliaru F, Putzu C et al (2005) Cardiac function in borderline hypothyroidism: a study by pulsed wave tissue doppler imaging. Eur J Endocrinol 152:527–533

    Article  CAS  PubMed  Google Scholar 

  22. Biondi B, Fazio S, Palmieri EA et al (1999) Left ventricular diastolic dysfunction in patients with subclinical hypothyroidism. J Clin Endocrinol Metab 84:2064–2067

    Article  CAS  PubMed  Google Scholar 

  23. Rodondi N, Bauer DC, Cappola AR et al (2008) Subclinical thyroid dysfunction, cardiac function, and the risk of heart failure. The Cardiovascular Health study. J Am Coll Cardiol 52:1152–1159

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Biondi B, Palmieri EA, Lombardi G, Fazio S (2002) Effects of subclinical thyroid dysfunction on the heart. Ann Intern Med 137:904–914

    Article  PubMed  Google Scholar 

  25. Biondi B, Palmieri EA, Lombardi G, Fazio S (2002) Subclinical hypothyroidism and cardiac function. Thyroid 12:505–510

    Article  PubMed  Google Scholar 

  26. Arem R, Rokey R, Kiefe C, Escalante DA, Rodriguez A (1996) Cardiac systolic and diastolic function at rest and exercise in subclinical hypothyroidism: effect of thyroid hormone therapy. Thyroid 6:397–402

    Article  CAS  PubMed  Google Scholar 

  27. Weber T, O’Rourke MF, Ammer M, Kvas E, Punzengruber C, Eber B (2008) Arterial stiffness and arterial wave reflections are associated with systolic and diastolic function in patients with normal ejection fraction. Am J Hypertens 21:1194–1202

    Article  PubMed  Google Scholar 

  28. Desai AS, Mitchell GF, Fang JC, Creager MA (2009) Central aortic stiffness is increased in patients with heart failure and preserved ejection fraction. J Card Fail 15:658–664

    Article  PubMed  Google Scholar 

  29. Kang S, Fan HM, Li J et al (2010) Relationship of arterial stiffness and early mild diastolic heart failure in general middle and aged population. Eur Heart J 31:2799–2807

    Article  PubMed  Google Scholar 

  30. Paglia A, Sasso L, Pirozzi F et al (2014) Arterial wave reflections and ventricular–vascular interaction in patients with left ventricular systolic dysfunction. Int Heart J 55:526–532

    Article  PubMed  Google Scholar 

  31. Lüers C, Trippel TD, Seeländer S et al (2017) Arterial stiffness and elevated left ventricular filling pressure in patients at risk for the development or a previous diagnosis of HF-A subgroup analysis from the DIAST-CHF study. J Am Soc Hypertens 11(5):303–313

    Article  PubMed  Google Scholar 

  32. McEniery CM, Wallace S, Mackenzie IS et al (2006) Endothelial function is associated with pulse pressure, pulse wave velocity, and augmentation index in healthy humans. Hypertension 48:602–608

    Article  CAS  PubMed  Google Scholar 

  33. Lee SW, Cho KI, Kim HS, Heo JH, Cha TJ (2015) The impact of subclinical hypothyroidism or thyroid autoimmunity on coronary vasospasm in patients without associated cardiovascular risk factors. Korean Circ J 45(2):125. https://doi.org/10.4070/kcj.2015.45.2.125

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  34. Nagasaki T, Inaba M, KumedaY et al (2005) Increased pulse wave velocity in subclinical hypothyroidism. J Clin Endocrinol Metab 91:154–158

    Article  CAS  PubMed  Google Scholar 

  35. Masaki M, Komamura K, Goda A et al (2014) Elevated arterial stiffness and diastolic dysfunction in subclinical hypothyroidism. Circ J 78(6):1494–1500

    Article  CAS  PubMed  Google Scholar 

  36. Owen PJ, Rajiv C, Vinereanu D, Mathew T, Fraser AG, Lazarus JH (2006) Subclinical hypothyroidism, arterial stiffness, and myocardial reserve. J Clin Endocrinol Metab 91(6):2126–2132

    Article  CAS  PubMed  Google Scholar 

  37. Mause SF, Weber C (2010) Microparticles: protagonists of a novel communication network for intercellular information exchange. Circ Res 107(9):1047–1057

    Article  CAS  PubMed  Google Scholar 

  38. Distler JH, Huber LC, Gay S, Distler O, Pisetsky DS (2006) Microparticles as mediators of cellular cross-talk in inflammatory disease. Autoimmunity 39(8):683–690

    Article  CAS  PubMed  Google Scholar 

  39. Nozaki T, Sugiyama S, Sugamura K et al (2010) Prognostic value of endothelial microparticles in patients with heart failure. Eur J Heart Fail 12(11):1223–1228

    Article  PubMed  Google Scholar 

  40. Yong PJ, Koh CH, Shim WS (2013) Endothelial microparticles: missing link in endothelial dysfunction? Eur J Prev Cardiol 20(3):496–512

    Article  PubMed  Google Scholar 

  41. Berezin AE, Kremzer AA, Martovitskaya YV, Samura TA, Berezina TA (2015) The association of subclinical hypothyroidism and pattern of circulating endothelial-derived microparticles among chronic heart failure patients. Res Cardiovasc Med 4(4):e29094

    Article  PubMed  PubMed Central  Google Scholar 

  42. Berezin AE, Kremzer AA, Martovitskaya YV et al (2015) The predictive role of circulating microparticles in patients with chronic heart failure. BBA Clin 3:18–24

    Article  PubMed  Google Scholar 

  43. Berezin AE, Kremzer A, Berezina T, Martovitskaya Y (2016) The signature of circulating microparticles in heart failure patients with metabolic syndrome. J Circ Biomark 5:1849454416663659

    PubMed  PubMed Central  Google Scholar 

  44. Berezin AE, Kremzer AA, Martovitskaya YV, Samura TA, Berezina TA (2016) Pattern of circulating endothelial-derived microparticles among chronic heart failure patients with dysmetabolic comorbidities: the impact of subclinical hypothyroidism. Diabetes Metab Syndr 10(1):29–36

    Article  PubMed  Google Scholar 

  45. Paulus WJ, Tschope C (2013) A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation. J Am Coll Cardiol 62:263–271

    Article  PubMed  Google Scholar 

  46. Maaten JM, Damman K, Verhaar MC et al (2016) Connecting heart failure with preserved ejection fraction and renal dysfunction: the role of endothelial dysfunction and inflammation. Eur J Heart Fail 18:588–598

    Article  PubMed  Google Scholar 

  47. Gupta G, Sharma P, Kumar P, Itagappa M (2015) Study on subclinical hypothyroidism and its association with various inflammatory markers. J Clin Diagn Res 9(11):BC04–B6

    CAS  PubMed  PubMed Central  Google Scholar 

  48. Vaya A, Gimenez C, Sarnago A et al (2014) Subclinical hypothyroidism and cardiovascular risk. Clin Hemorheol Microcirc 58:1–7

    PubMed  Google Scholar 

  49. Taddei S, Caraccio N, Virdis A et al (2006) Low grade systemic inflammation causes endothelial dysfunction in patients with hashimato’s thyroiditis. J Clin Endocrinol Metab 91:5076–5082

    Article  CAS  PubMed  Google Scholar 

  50. Dillmann WH (1990) Biochemical basis of thyroid hormone action in the heart. Am J Med 88:626–632

    Article  CAS  PubMed  Google Scholar 

  51. Türemen EE, Çetinarslan B, Sahin T, Cantürk Z, Tarkun I (2011) Endothelial dysfunction and low grade chronic inflammation in subclinical hypothyroidism due to autoimmune thyroiditis. Endocr J 58:349–354

    Article  PubMed  Google Scholar 

  52. Walsh JP, Bremner AP, Bulsara MK et al (2005) Subclinical thyroid dysfunction as a risk factor for cardiovascular disease. Arch Intern Med 165:2467–2472

    Article  PubMed  Google Scholar 

  53. Pesic MM, Radojkovic D, Antic S, Kocic R, Stankovic-Djordjevic D (2015) Subclinical hypothyroidism: association with cardiovascular risk factors and components of metabolic syndrome. Biotechnol Biotechnol Equip 29:157–163

    Article  CAS  PubMed  Google Scholar 

  54. Ilic S, Tadic M, Ivanovic B, Caparevic Z, Trbojevic B, Celic V (2013) Left and right ventricular structure and function in subclinical hypothyroidism: the effects of one-year levothyroxine treatment. Med Sci Monit 10:19:960–968

    Google Scholar 

  55. Monzani F, Di Bello V, Caraccio N et al (2001) Effect of levothyroxine on cardiac function and structure in subclinical hypothyroidism: a double blind, placebo-controlled study. J Clin Endocrinol Metab 86(3):1110–1115

    Article  CAS  PubMed  Google Scholar 

  56. Mishra TK, Routray SN, Das S, Behera M (2005) Left ventricular dysfunction in patients with subclinical hypothyroidism and its reversibility after hormone therapy. J Assoc Physicians India 53:943–946

    CAS  PubMed  Google Scholar 

  57. Aghini-Lombardi F, Di Bello V, Talini E et al (2006) Early textural and functional alterations of left ventricular myocardium in mild hypothyroidism. Eur J Endocrinol 155:3–9

    Article  CAS  PubMed  Google Scholar 

  58. Iqbal A, Schirmer H, Lunde P et al (2007) Thyroid stimulating hormone and left ventricular function. J Clin Endocrinol Metab 92:3504–3510

    Article  CAS  PubMed  Google Scholar 

  59. McDermott MM, Feinglass J, Sy J, Gheorghiade M (1995) Hospitalized congestive heart failure patients with preserved versus abnormal left ventricular systolic function: Clinical characteristics and drug therapy. Am J Med 99:629–635

    Article  CAS  PubMed  Google Scholar 

  60. Bell GM, Todd WT, Forfar JC et al. End-organ responses to thyroxine therapy in subclinical hypothyroidism. Clin Endocrinol (Oxf) 22:83–89

  61. Kahaly GJ (2000 Aug) Cardiovascular and atherogenic aspects of subclinical hypothyroidism. Thyroid 10(8):665–679

    Article  CAS  PubMed  Google Scholar 

  62. Kirchhof G, Lindner JF, Achenbach S et al (2018 Mar) Stratified prevention: opportunities and limitations. Report on the 1st interdisciplinary cardiovascular workshop in Augsburg. Clin Res Cardiol 107(3):193–200

    Article  CAS  PubMed  Google Scholar 

  63. Störk S, Handrock R, Jacob J et al (2017) Treatment of chronic heart failure in Germany: a retrospective database study. Clin Res Cardiol 106(11):923–932

    Article  PubMed  PubMed Central  Google Scholar 

  64. Stott DJ, Rodondi N, Kearney PM, TRUST Study Group (2017) Thyroid Hormone Therapy for Older Adults with Subclinical Hypothyroidism. N Engl J Med 376:2534–2544

    Article  CAS  PubMed  Google Scholar 

  65. Vadiveloo T, Donnan PT, Murphy MJ, Leese GP (2013) Age- and gender-specific TSH reference intervals in people with no obvious thyroid disease in Tayside, Scotland: the Thyroid Epidemiology, Audit, and Research Study (TEARS). J Clin Endocrinol Metab 98:1147–1153

    Article  CAS  PubMed  Google Scholar 

  66. Waring AC, Arnold AM, Newman AB, Buzkova P, Hirsch C, Cappola AR (2012) Longitudinal changes in thyroid function in the oldest old and survival: the cardiovascular health study all-stars study. J Clin Endocrinol Metab 97:3944–3950

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  67. Surks MI, Boucai L (2010) Age- and race-based serum thyrotropin reference limits. J Clin Endocrinol Metab 95:496–502

    Article  CAS  PubMed  Google Scholar 

  68. Surks MI, Hollowell JG (2007) Age-specific distribution of serum thyrotropin and antithyroid antibodies in the U.S. population: implications for the prevalence of subclinical hypothyroidism. J Clin Endocrinol Metab 92:4575–4582

    Article  CAS  PubMed  Google Scholar 

  69. Biondi B, Wartofsky L (2014) Treatment with thyroid hormone. Endocr Rev 35:433–512

    Article  CAS  PubMed  Google Scholar 

  70. Gharib H, Tuttle RM, Baskin HJ, Fish LH, Singer PA, McDermott MT (2005) Subclinical thyroid dysfunction: a joint statement on management from the American Association of Clinical Endocrinologists, the American Thyroid Association, and the Endocrine Society. J Clin Endocrinol Metab 90:581–585

    Article  CAS  PubMed  Google Scholar 

  71. Cooper DS, Biondi B (2012) Subclinical thyroid disease. Lancet 379:1142–1154

    Article  Google Scholar 

  72. Rhee SS, Pearce EN (2011) Update: Systemic Diseases and the Cardiovascular System (II). The endocrine system and the heart: a review. Rev Esp Cardiol 64:220–231

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Hypertension, Chair of Nephrology and Hypertension, Medical University of Lodz (UMED), Lodz, Poland

    Agata Bielecka-Dabrowa & Maciej Banach

  2. Department of Cardiology and Pneumology, University Medical Centre Goettingen (UMG), Georg-August-University, Robert-Koch-Strasse 40, 37075, Goettingen, Germany

    Breno Godoy, Tsuyoshi Suzuki & Stephan von Haehling

  3. Department of Cardiology, Tokyo Women’s Medical University, Tokyo, Japan

    Tsuyoshi Suzuki

  4. Department of Cardiology and Congenital Diseases of Adults, Polish Mother’s Memorial Hospital Research Institute (ICZMP), Lodz, Poland

    Agata Bielecka-Dabrowa

Authors
  1. Agata Bielecka-Dabrowa
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Breno Godoy
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Tsuyoshi Suzuki
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Maciej Banach
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Stephan von Haehling
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Stephan von Haehling.

Ethics declarations

Conflict of interest

On behalf of all authors, the corresponding author states that there are no conflicts of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bielecka-Dabrowa, A., Godoy, B., Suzuki, T. et al. Subclinical hypothyroidism and the development of heart failure: an overview of risk and effects on cardiac function. Clin Res Cardiol 108, 225–233 (2019). https://doi.org/10.1007/s00392-018-1340-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00392-018-1340-1

Keywords

Search

Navigation